Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.983 | 242 | 3 | 1985 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.965 | 143 | 11 | 1991 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.700 | None | 1.000 | 71 | 0 | 1996 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.980 | 102 | 3 | 1995 | 2019 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.480 | None | 1.000 | 8 | 1 | 1999 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.400 | None | 0.986 | 73 | 1 | 1995 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.400 | None | 1.000 | 35 | 1 | 1997 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.390 | None | 1.000 | 9 | 0 | 1992 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.370 | None | 1.000 | 7 | 2 | 2001 | 2015 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2003 | 2020 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 1996 | 2017 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.360 | None | 0.857 | 6 | 0 | 2005 | 2018 | ||||||||
|
mitogen-activated protein kinase kinase 4 | 0.559 | 0.692 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 1 | 2004 | 2019 | ||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 2002 | 2020 | ||||||||
|
heterogeneous nuclear ribonucleoprotein A2/B1 | 0.566 | 0.808 | 1.00 |
|
disease | 0.240 | None | 1.000 | 4 | 0 | 2011 | 2017 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.240 | None | 1.000 | 4 | 1 | 1990 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.962 | 23 | 1 | 2009 | 2018 | |||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
disease | 0.200 | None | 1.000 | 10 | 3 | 2010 | 2018 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.190 | None | 1.000 | 9 | 0 | 2011 | 2019 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.160 | None | 1.000 | 6 | 1 | 2010 | 2019 | ||||||||
|
activin A receptor type 1B | 0.663 | 0.385 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2001 | 2016 | ||||||||
|
DAB adaptor protein 2 | 0.565 | 0.731 | 0.41 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
NOC2 like nucleolar associated transcriptional repressor | 0.593 | 0.731 | 2.9E-29 |
|
disease | 0.120 | None | 1.000 | 2 | 1 | 2018 | 2019 | ||||||||
|
hepatocyte nuclear factor 4 gamma | 0.729 | 0.423 | 7.1E-02 |
|
disease | 0.120 | None | 0.500 | 2 | 1 | 2016 | 2018 |